Drug stocks inch up; Gilead gains on HIV study
January 06, 2010 at 10:49 AM EST
Drug stocks inched higher early Wednesday as shares of Gilead Sciences rose on a positive Phase II study for an HIV combination therapy that includes two new drug candidates.
